News - MedTech

CEO resigns at troubled plc TruSpine

The CEO of troubled MedTech TruSpine Technologies Plc has resigned amid shareholder unrest. Laure...

Founder completes boardroom coup at BenevolentAI

A boardroom coup at BenevolentAI has been completed after all resolutions proposed at its annual gen...

PlaqueTec raises £6.4m to target coronary artery disease

PlaqueTec, a company aiming to advance precision medicine for coronary artery disease, has raised £...

£247m takeover at Cambridge breast cancer tech firm

A Cambridge-headquartered company developing technology for breast cancer surgery is set to be acqui...

Locate Bio raises £9.2m to develop bone graft substitute

Locate Bio has raised £9.2 million to fund a clinical study of LDGraft, a bone graft substitute for...

Could Owlstone detect TB & HIV from breath?

Owlstone Medical has secured £5.2 million to explore a path by which breath-based testing could be ...

SleepCogni wins funding for child insomnia therapy trial

A company which provides handheld devices that help people self-manage insomnia has received over £...

CN Bio raises £17m to expand organ-on-a-chip solutions

‘Organ-on-a-chip’ firm CN Bio has raised almost £17 million in the first close of its Series B ...

BenevolentAI to close US office, slash more jobs amid boardroom coup

BenevolentAI is to slash more jobs and close its US office amid a boardroom coup led by founder Ken ...

Qureight backed with £7m to tackle lung & heart disease

Qureight has raised almost £7 million in Series A funding to accelerate drug development in lung an...

Founder leads boardroom coup at BenevolentAI

The founder of BenevolentAI is leading a boardroom coup at the high-profile MedTech. Ken Mulvany ...

e-therapeutics plc looks to US, slams risk appetite of UK investors

e-therapeutics plc plans to de-list from the London Stock Exchange’s junior AIM market after slamm...